Libros importados hasta 50% OFF + Envío Gratis a todo USA   Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Recent Developments in Myelodysplastic Syndromes (in English)
Type
Physical Book
Publisher
Language
Inglés
Pages
120
Format
Hardcover
Dimensions
24.4 x 17.0 x 0.8 cm
Weight
0.39 kg.
ISBN13
9781789854770
Categories

Recent Developments in Myelodysplastic Syndromes (in English)

Fuchs, Ota (Author) · Intechopen · Hardcover

Recent Developments in Myelodysplastic Syndromes (in English) - Fuchs, Ota

Physical Book

$ 124.00

$ 155.00

You save: $ 31.00

20% discount
  • Condition: New
It will be shipped from our warehouse between Tuesday, July 09 and Wednesday, July 10.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Recent Developments in Myelodysplastic Syndromes (in English)"

This book deals with the rapid progress in the area of myelodysplastic syndromes (MDS). MDS are a group of age-associated heterogeneous malignant bone marrow stem cell disorders. MDS are characterized by ineffective hematopoiesis, which leads to refractory cytopenias and to clonal instability. Patients with MDS have myeloid dysplasia, intramedullary apoptosis and an increased risk of transformation to acute myeloid leukemia (AML). The use of next generation sequencing has allowed for the identification of molecular mutations in several genes in about 90% of MDS patients. Several mutations will likely be incorporated into future prognostic scoring systems for MDS. About 50% of MDS cases are characterized by the presence of cytogenetic abnormalities. The correct morphological and cytogenetic analysis interpretation plays an important role in diagnosis and prognosis of these disorders. Cell death and an inflammatory gene signature are associated with MDS. Better understanding of the genetic and molecular mechanisms of MDS pathogenesis provides an opportunity for new treatment strategies to be developed. Promising novel therapies targeting pathophysiological mechanisms of MDS are being studied but the drugs currently used in MDS therapy remain limited. The only curative therapy for MDS is allogeneic hematopoietic stem cell transplantation. Recent advances in strategies to minimize transplant-related toxicity make this treatment possible for more MDS patients who are sufficiently fit.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews